Promoter hypermethylation of the p16 and Wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International Journal of Oncology

• Publication date

  2009-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJO_00000437PMID 19787276
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relationship of phospho-pRb (Ser-807/811) level to exposure to tobacco smoke in primary non-small cell lung cancer.

  2009cited by this paper
• Clinical significance of aberrant methylation of prostaglandin E receptor 2 (PTGER2) in nonsmall cell lung cancer

  2008cited by this paper
• DNA methylation markers and early recurrence in stage I lung cancer.

  2008cited by this paper
• Synchronous Alterations of Wnt and Epidermal Growth Factor Receptor Signaling Pathways through Aberrant Methylation and Mutation in Non–Small Cell Lung Cancer

  2007cited by this paper
• High frequency of p16 promoter methylation in non-small cell lung carcinomas from Chile.

  2007cited by this paper
• Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients.

  2006cited by this paper
• Exclusive mutation in epidermal growth factor receptor gene, HER‐2, and KRAS, and synchronous methylation of nonsmall cell lung cancer

  2006cited by this paper
• Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer.

  2006cited by this paper
• The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.

  2006cited by this paper
• Retinoblastoma regulatory pathway in lung cancer.

  2006cited by this paper
• Aberrant methylation of Reprimo in lung cancer.

  2005cited by this paper
• Patient Subsets Benefiting from Adjuvant Therapy Following Surgical Resection of Non–Small Cell Lung Cancer

  2005cited by this paper
• Wnt Inhibitory Factor-1 Is Silenced by Promoter Hypermethylation in Human Lung Cancer

  2004cited by this paper
• RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells.

  2004cited by this paper
• Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma

  2004cited by this paper
• Value of p16INK4a and RASSF1A Promoter Hypermethylation in Prognosis of Patients with Resectable Non–Small Cell Lung Cancer

  2004cited by this paper
• Secreted antagonists of the Wnt signalling pathway

  2003cited by this paper
• Reactivating the expression of methylation silenced genes in human cancer

  2002cited by this paper
• CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future

  2002cited by this paper
• The fundamental role of epigenetic events in cancer

  2002cited by this paper
• Aberrant DNA methylation in lung cancer: biological and clinical implications.

  2002cited by this paper
• Antisense MBD2 gene therapy inhibits tumorigenesis

  2002cited by this paper
• Cancer Statistics, 2001

  2001cited by this paper
• DNA methylation profiles of lung tumors.

  2001cited by this paper
• A gene hypermethylation profile of human cancer.

  2001cited by this paper
• Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience.

  2001cited by this paper
• In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis.

  1999cited by this paper
• Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis.

  1998cited by this paper
• Revisions in the International System for Staging Lung Cancer.

  1997cited by this paper
• Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

  1995cited by this paper

• Blood-based biomarkers derived from tumor-informed DNA methylation analysis for lung adenocarcinoma

  2025cites this paper
• Reprimo ( RPRM ): A Tumor Suppressor That Induces Extrinsic Apoptosis via YAP Signaling

  2025cites this paper
• Role of gremlin-1 in the pathophysiology of the adipose tissues.

  2022cites this paper
• Targeting DNA methyltransferases in Non-small-cell lung cancer.

  2021cites this paper
• Anti proliferative and apoptotic effects on pancreatic cancer cell lines indicate new roles for ANGPTL8 (Betatrophin)

  2020cites this paper
• Structure, function and disease relevance of Wnt inhibitory factor 1, a secreted protein controlling the Wnt and hedgehog pathways

  2019cites this paper
• Association between SFRP promoter hypermethylation and different types of cancer: A systematic review and meta-analysis

  2019cites this paper
• WIF1 Qualitative-Methylation from Peripheral Blood Could Not Be Used as Biomarker for The Risk of Nasopharyngeal Carcinoma or Smoking Behavior in Yogyakarta Panel

  2019cites this paper
• Wnt inhibitory factor-1-mediated autophagy inhibits Wnt/β-catenin signaling by downregulating dishevelled-2 expression in non-small cell lung cancer cells.

  2018cites this paper
• Promoter methylation of WNT inhibitory factor-1 may be associated with the pathogenesis of multiple human tumors

  2018cites this paper
• Methylation analysis for multiple gene promoters in non-small cell lung cancers in high indoor air pollution region in China.

  2018cites this paper
• DNA and Histone Methylation in Lung Cancer

  2017cites this paper
• WNT inhibitory factor 1 promoter hypermethylation is an early event during gallbladder cancer tumorigenesis that predicts poor survival.

  2017cites this paper
• Reprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor α-Positive Breast Cancer

  2017cites this paper
• PREDICTING RECURRENCE OF NON-SMALL CELL LUNG CANCER

  2017cites this paper
• Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma

  2017cites this paper
• Hypermethylation of WIF1 and its inhibitory role in the tumor growth of endometrial adenocarcinoma

  2017cites this paper
• A new insight on reciprocal relationship between microRNA expression and epigenetic modifications in human lung cancer

  2017cites this paper
• BMP pathway suppression is an early event in inflammation-driven colon neoplasmatogenesis of uPA-deficient mice

  2016cites this paper
• Clinicopathological significance of WIF1 hypermethylation in NSCLC, a meta-analysis and literature review

  2016influential citation
• The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer

  2016cites this paper
• Coexistence of p16/CDKN2A homozygous deletions and activating EGFR mutations in lung adenocarcinoma patients signifies a poor response to EGFR-TKIs.

  2016cites this paper
• Promoter hypermethylation of Wnt inhibitory factor-1 in patients with lung cancer

  2016cites this paper
• Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line

  2016cites this paper
• Native Oligodendrocytes in Astrocytomas Might Inhibit Tumor Proliferation by WIF1 Expression

  2016cites this paper
• Clinicopathological significance and potential drug target of rUnX3 in non-small cell lung cancer: a meta-analysis the mechanism of initiation, progression, and identification of prognostic markers

  2015cites this paper
• Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis

  2015cites this paper
• Epigenetics of lung cancer.

  2015cites this paper
• Alterations in DNA Methylation May Be the Key to Early Detection and Treatment of Schistosomal Bladder Cancer

  2015cites this paper
• Clinicopathological significance and potential drug target of rUnX3 in non-small cell lung cancer: a meta-analysis the mechanism of initiation, progression, and identification of prognostic markers

  2015cites this paper
• The negative regulators of Wnt pathway—DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival

  2014cites this paper
• The role of genetic and other biomarkers in NSCLC prognosis

  2014cites this paper
• Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer.

  2014cites this paper
• Association between RUNX3 promoter methylation and non-small cell lung cancer: a meta-analysis.

  2014cites this paper
• Clinical Correlates of Promoter Hypermethylation of Four Target Genes in Head and Neck Cancer: A Cooperative Group Correlative Study

  2013influential citation
• The Prognostic Value of p16 Hypermethylation in Cancer: A Meta-Analysis

  2013cites this paper
• Oncogenic Wnt/β-catenin signalling pathways in the cancer-resistant epididymis have implications for cancer research.

  2013cites this paper
• Genome-wide DNA methylation assay reveals novel candidate biomarker genes in cervical cancer

  2013cites this paper
• Promoter methylation of WNT inhibitory factor-1 and expression pattern of WNT/β-catenin pathway in human astrocytoma: pathologic and prognostic correlations

  2013cites this paper
• The Prognostic Value of Epigenetic Silencing of p16 Gene in NSCLC Patients: A Systematic Review and Meta-Analysis

  2013cites this paper
• Wif1 hypermethylation as unfavorable prognosis of non-small cell lung cancers with EGFR mutation

  2013cites this paper
• DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer

  2012cites this paper
• Targeting epigenetic mediators of gene expression in thoracic malignancies.

  2012cites this paper
• DNA Methylation in the Pathogenesis of Head and Neck Cancer

  2012cites this paper
• Promoter methylation of Wnt antagonist DKK1 gene and prognostic value in Korean patients with non-small cell lung cancers

  2012cites this paper
• DNA methylation changes associated with risk factors in tumors of the upper aerodigestive tract

  2012cites this paper
• Quantitative analysis of multiple gene promoter methylation in Korean non-small cell lung cancer patients and its association study with cancer risk factor and survival

  2012cites this paper
• Promoter and histone methylation and p16INK4A gene expression in colon cancer

  2012cites this paper
• Altered p16INK4 and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung Cancer

  2012cites this paper
• DNA methylation in early neoplasia

  2011cites this paper
• Methylation profiling in non-small cell lung cancer: clinical implications.

  2011cites this paper
• Absence of Runx3 expression in normal gastrointestinal epithelium calls into question its tumour suppressor function

  2011cites this paper
• MicroRNA, epigenetic machinery and lung cancer

  2011cites this paper
• Genetic and epigenetic changes in lung carcinoma and their clinical implications

  2011cites this paper
• Detection of p16INK4a Promoter Methylation Status &1QJ;in Non-small Cell Lung Cancer by a Fluorescence Polarization Assay

  2011cites this paper
• Epigenetic Alterations as Contributors to the Pathogenesis, Detection, Prognosis and Treatment of Human Pre-invasive Neoplasia

  2011cites this paper
• Identification of unknown epigenetically regulated genes in non-small cell lung cancer

  2011cites this paper
• Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer

  2010cites this paper
• Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis

  2010cites this paper